查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2008924

骨骼和礦物質診斷檢測市場報告：按產品類型、檢測類型、應用和地區分類（2026-2034 年）

Bone and Mineral Diagnostic Testing Market Report by Product, Test Type (Enzyme-Linked Immunosorbent Assay, Clinical Laboratory Improvement Amendments, and Others), Application, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球骨骼和礦物質診斷檢測市場規模達11.3億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到15.6億美元，2026年至2034年的複合年成長率為3.44%。骨骼相關疾病發病率的顯著上升、對這些疾病的早期診斷和預防需求的成長以及檢測自動化技術的不斷進步是推動市場成長的主要因素。

骨骼和礦物質診斷測試採用酵素連結免疫吸附試驗 (ELISA)、化學發光免疫分析 (CLIA) 和放射免疫分析 (RIA) 等技術，用於檢測骨骼和礦物質的異常情況，並診斷和評估治療效果。骨骼和礦物質代謝紊亂是一個總稱，涵蓋一系列因鈣、磷和維生素 D 等礦物質缺乏而導致骨骼脆弱的疾病。大多數情況下，這些測試是非侵入性、無痛的，並且只需要極少的藥物或手術。此外，一些骨骼和礦物質診斷測試通常採用多種方法聯合進行。 X 光、電腦斷層掃描 (CT) 或磁振造影(MRI) 有助於識別和排除骨折、磨損和骨骼錯位。此外，骨骼密度（也稱為骨骼密度骨骼密度檢測法）和骨掃描（骨閃爍顯像）可以檢測骨骼中礦物質和骨骼代謝的詳細信息，並顯示各種骨骼結構。此外，骨骼切片檢查和骨髓切片檢查也是重要的骨骼診斷測試類型，其中使用細針採集骨組織以檢測與疾病相關的變化。

骨骼和礦物質診斷檢測市場的發展趨勢：

全球骨骼相關疾病發生率的顯著上升是推動市場發展的主要因素。這被認為是由於久坐不動的生活方式導致維生素D缺乏所致。因此，對這些疾病早期診斷和預防的需求不斷成長，也促使公眾更多地參與各種篩檢。此外，自動化檢測技術的不斷進步提高了診斷測試的準確性，縮短了處理時間，並提高了結果的精確度，為市場創造了巨大的成長潛力。然而，成本上升、保險報銷有限以及某些骨骼診斷測試的檢測能力不足是限制市場成長的主要因素。另一方面，即時診斷（POC）測試的廣泛應用以及公眾預防醫學意識的顯著提高，為市場帶來了積極的前景。此外，政府和非營利組織為促進公眾了解各種診斷測試程序而採取的積極措施也推動了市場成長。此外，老年人口的成長（老年人更容易罹患這些疾病）也加劇了骨骼疾病發生率的上升。其他推動市場發展的因素包括快速的都市化、不斷上漲的醫療保健成本、製造商推出新產品以及廣泛的研發活動。

本報告解答的主要問題

  • 全球骨骼和礦物質診斷檢測市場迄今的發展如何？預計未來幾年將如何發展？
  • 全球骨骼和礦物質診斷檢測市場的促進因素、限制因素和機會是什麼？
  • 主要區域市場有哪些？
  • 哪個國家的骨骼和礦物質診斷檢測市場最具吸引力？
  • 以產品來看，市場區隔是如何計算的？
  • 按檢測類型分類的市場區隔如何？
  • 按應用領域分類的市場區隔如何？
  • 全球骨骼和礦物質診斷檢測市場的競爭格局如何？
  • 全球骨骼和礦物質診斷檢測市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球骨骼與礦物質診斷檢測市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 檢測/耗材
  • 裝置

第7章 市場區隔：依測試類型分類

  • 酵素免疫分析法（ELISA）
  • 臨床實驗室改良（CLIA）
  • 其他

第8章 市場區隔：依應用領域分類

  • 維生素D檢測
  • 骨骼代謝

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章：促進、抑制與機遇

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Abbott Laboratories
    • bioMerieux SA
    • DiaSorin SpA
    • Epitope Diagnostics Inc.
    • F. Hoffmann-La Roche AG
    • QuidelOrtho Corporation
    • Siemens Healthineers AG（Siemens AG）
Product Code: SR112026A7106

The global bone and mineral diagnostic testing market size reached USD 1.13 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 1.56 Billion by 2034, exhibiting a growth rate (CAGR) of 3.44% during 2026-2034. A considerable increase in the incidences of bone-related diseases, the escalating demand for early disease diagnosis and prevention, and continual technological advancements in the automation of assay represent some of the key factors driving the market.

Bone and mineral diagnostic tests detect bone and mineral disorders that are performed using technologies, such as ELISA, CLIA, and RIA, to diagnose and assess treatment response. A bone and mineral metabolism disorder is a general term used to describe a range of conditions that can weaken bones due to mineral deficiencies like calcium, phosphorus, and vitamin D. In most cases, these tests are non-invasive, painless, and require minimal medication or administration, and several bone and mineral diagnostic tests are often performed using a combination method. The use of X-rays, computed tomography (CT) scans, or magnetic resonance imaging (MRI) can help identify or rule out fractures, wear and tear, and abnormal bone positions. Additionally, bone density tests (also known as bone densitometry or osteodensitometry) and bone scans (bone scintigraphy) detect the minerals in the bones, details on bone metabolism, and depict the different bone structures. Besides this, bone biopsies and bone marrow biopsies are also important forms of bone diagnostic testing, in which a thin needle is used to remove bone tissue to detect disease-related changes.

BONE AND MINERAL DIAGNOSTIC TESTING MARKET TRENDS:

A considerable increase in the incidences of bone-related diseases on the global level is a significant factor driving the market. This can be attributed to the rising prevalence of sedentary lifestyle leading to deficiency of vitamin D. In line with this, the escalating demand for early disease diagnosis and prevention is also resulting in a higher uptake of various tests among the masses. Moreover, continual technological advancements in the automation of assay for enhanced diagnostic testing with lower turnaround times and increased accuracy in output are creating lucrative growth opportunities in the market. However, the augmenting costs of several bone diagnostic tests, limited reimbursements, along with limited detection capability are acting as significant factors that are restraining the market growth. On the contrary, the expansion of a wide range of point-of-care (POC) diagnostic tests and a considerable rise in public awareness toward preventive healthcare is creating a positive outlook for the market. The market is further driven by favorable initiatives undertaken by the government and non-profit organizations for promoting awareness about various diagnostic test procedures among the masses. Apart from this, the growing geriatric population that is more susceptible to developing these ailments is leading to the increasing incidences of bone disorders. Some of the other factors contributing to the market include rapid urbanization, rising medical expenditure, new product launches by the manufacturers, and extensive research and development (R&D) activities.

KEY MARKET SEGMENTATION:

Product Insights:

  • Assays/Consumables
  • Instruments

Test Type Insights:

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Clinical Laboratory Improvement Amendments (CLIA)
  • Others

Application Insights:

  • Vitamin D Testing
  • Bone Metabolism

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for bone and mineral diagnostic testing. Some of the factors driving the North America bone and mineral diagnostic testing market include the expanding geriatric population, rising healthcare expenditure, extensive research and development (R&D) activities conducted by key players, etc.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global bone and mineral diagnostic testing market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, bioMerieux SA, DiaSorin S.p.A., Epitope Diagnostics Inc., F. Hoffmann-La Roche AG, QuidelOrtho Corporation, Siemens Healthineers AG (Siemens AG), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global bone and mineral diagnostic testing market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global bone and mineral diagnostic testing market?
  • What are the key regional markets?
  • Which countries represent the most attractive bone and mineral diagnostic testing markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the application?
  • What is the competitive structure of the global bone and mineral diagnostic testing market?
  • Who are the key players/companies in the global bone and mineral diagnostic testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bone and Mineral Diagnostic Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Assays/Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Enzyme-Linked Immunosorbent Assay (ELISA)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinical Laboratory Improvement Amendments (CLIA)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Vitamin D Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Bone Metabolism
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 bioMerieux SA
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 DiaSorin S.p.A.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Epitope Diagnostics Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 F. Hoffmann-La Roche AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 QuidelOrtho Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Siemens Healthineers AG (Siemens AG)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Bone and Mineral Diagnostic Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Bone and Mineral Diagnostic Testing Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Bone and Mineral Diagnostic Testing Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Bone and Mineral Diagnostic Testing Market: Breakup by Test Type (in %), 2025
  • Figure 6: Global: Bone and Mineral Diagnostic Testing Market: Breakup by Application (in %), 2025
  • Figure 7: Global: Bone and Mineral Diagnostic Testing Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Bone and Mineral Diagnostic Testing (Assays/Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Bone and Mineral Diagnostic Testing (Assays/Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Bone and Mineral Diagnostic Testing (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Bone and Mineral Diagnostic Testing (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Bone and Mineral Diagnostic Testing (Enzyme-Linked Immunosorbent Assay (ELISA)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Bone and Mineral Diagnostic Testing (Enzyme-Linked Immunosorbent Assay (ELISA)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Bone and Mineral Diagnostic Testing (Clinical Laboratory Improvement Amendments (CLIA)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Bone and Mineral Diagnostic Testing (Clinical Laboratory Improvement Amendments (CLIA)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Bone and Mineral Diagnostic Testing (Other Test Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Bone and Mineral Diagnostic Testing (Other Test Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Bone and Mineral Diagnostic Testing (Vitamin D Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Bone and Mineral Diagnostic Testing (Vitamin D Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Bone and Mineral Diagnostic Testing (Bone Metabolism) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Bone and Mineral Diagnostic Testing (Bone Metabolism) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: North America: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: North America: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: United States: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: United States: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Canada: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Canada: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Asia-Pacific: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Asia-Pacific: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: China: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: China: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Japan: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Japan: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: India: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: India: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: South Korea: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: South Korea: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Australia: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Australia: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Indonesia: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Indonesia: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Others: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Others: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Europe: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Europe: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Germany: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Germany: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: France: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: France: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: United Kingdom: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: United Kingdom: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Italy: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Italy: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Spain: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Spain: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Russia: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Russia: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Others: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Others: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Latin America: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Latin America: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Brazil: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Brazil: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Mexico: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Mexico: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Middle East and Africa: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Middle East and Africa: Bone and Mineral Diagnostic Testing Market: Breakup by Country (in %), 2025
  • Figure 70: Middle East and Africa: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Global: Bone and Mineral Diagnostic Testing Industry: Drivers, Restraints, and Opportunities
  • Figure 72: Global: Bone and Mineral Diagnostic Testing Industry: Value Chain Analysis
  • Figure 73: Global: Bone and Mineral Diagnostic Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bone and Mineral Diagnostic Testing Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Bone and Mineral Diagnostic Testing Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Bone and Mineral Diagnostic Testing Market Forecast: Breakup by Test Type (in Million USD), 2026-2034
  • Table 4: Global: Bone and Mineral Diagnostic Testing Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Bone and Mineral Diagnostic Testing Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Bone and Mineral Diagnostic Testing Market: Competitive Structure
  • Table 7: Global: Bone and Mineral Diagnostic Testing Market: Key Players